Logo image of ORP.PA

EMEIS SA (ORP.PA) Stock Fundamental Analysis

EPA:ORP - Euronext Paris - Matif - FR001400NLM4 - Common Stock - Currency: EUR

12.465  +0.15 (+1.24%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ORP. ORP was compared to 24 industry peers in the Health Care Providers & Services industry. While ORP is still in line with the averages on profitability rating, there are concerns on its financial health. ORP is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

ORP had positive earnings in the past year.
In the past year ORP had a positive cash flow from operations.
Of the past 5 years ORP 4 years were profitable.
In the past 5 years ORP always reported a positive cash flow from operatings.
ORP.PA Yearly Net Income VS EBIT VS OCF VS FCFORP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B -2B -3B -4B

1.2 Ratios

ORP has a better Return On Assets (9.74%) than 100.00% of its industry peers.
The Return On Equity of ORP (71.82%) is better than 100.00% of its industry peers.
Industry RankSector Rank
ROA 9.74%
ROE 71.82%
ROIC N/A
ROA(3y)-5.89%
ROA(5y)-3.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ORP.PA Yearly ROA, ROE, ROICORP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 100 150 200 250

1.3 Margins

ORP has a Profit Margin of 26.07%. This is amongst the best in the industry. ORP outperforms 100.00% of its industry peers.
ORP's Profit Margin has improved in the last couple of years.
ORP does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 26.07%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y85.55%
PM growth 5Y32.24%
GM growth 3YN/A
GM growth 5YN/A
ORP.PA Yearly Profit, Operating, Gross MarginsORP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

More info and screens

1

2. Health

2.1 Basic Checks

ORP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ORP has been reduced compared to 1 year ago.
Compared to 5 years ago, ORP has less shares outstanding
Compared to 1 year ago, ORP has an improved debt to assets ratio.
ORP.PA Yearly Shares OutstandingORP.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B
ORP.PA Yearly Total Debt VS Total AssetsORP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

ORP has an Altman-Z score of 0.39. This is a bad value and indicates that ORP is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.39, ORP is doing worse than 85.71% of the companies in the same industry.
A Debt/Equity ratio of 4.30 is on the high side and indicates that ORP has dependencies on debt financing.
ORP's Debt to Equity ratio of 4.30 is on the low side compared to the rest of the industry. ORP is outperformed by 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.3
Debt/FCF N/A
Altman-Z 0.39
ROIC/WACCN/A
WACC5.23%
ORP.PA Yearly LT Debt VS Equity VS FCFORP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 0.60 indicates that ORP may have some problems paying its short term obligations.
ORP has a Current ratio of 0.60. This is amonst the worse of the industry: ORP underperforms 85.71% of its industry peers.
A Quick Ratio of 0.60 indicates that ORP may have some problems paying its short term obligations.
ORP has a worse Quick ratio (0.60) than 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.6
ORP.PA Yearly Current Assets VS Current LiabilitesORP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 360.39% over the past year.
ORP shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 116.08% yearly.
Looking at the last year, ORP shows a quite strong growth in Revenue. The Revenue has grown by 11.04% in the last year.
The Revenue has been growing by 8.73% on average over the past years. This is quite good.
EPS 1Y (TTM)360.39%
EPS 3Y301.6%
EPS 5Y116.08%
EPS Q2Q%278.1%
Revenue 1Y (TTM)11.04%
Revenue growth 3Y9.84%
Revenue growth 5Y8.73%
Sales Q2Q%11.4%

3.2 Future

ORP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.14% yearly.
ORP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.11% yearly.
EPS Next Y99.7%
EPS Next 2Y41.51%
EPS Next 3Y26.14%
EPS Next 5YN/A
Revenue Next Year6.41%
Revenue Next 2Y9.12%
Revenue Next 3Y8.11%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ORP.PA Yearly Revenue VS EstimatesORP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B
ORP.PA Yearly EPS VS EstimatesORP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 100 -100 200

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ORP is valuated cheaply with a Price/Earnings ratio of 1.20.
Compared to the rest of the industry, the Price/Earnings ratio of ORP indicates a rather cheap valuation: ORP is cheaper than 100.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.22. ORP is valued rather cheaply when compared to this.
ORP is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 1.2
Fwd PE N/A
ORP.PA Price Earnings VS Forward Price EarningsORP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ORP.PA Per share dataORP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ORP's earnings are expected to grow with 26.14% in the coming years.
PEG (NY)0.01
PEG (5Y)0.01
EPS Next 2Y41.51%
EPS Next 3Y26.14%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ORP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMEIS SA

EPA:ORP (7/2/2024, 5:28:19 PM)

12.465

+0.15 (+1.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-14 2024-05-14
Earnings (Next)07-24 2024-07-24
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.98B
Analysts48.89
Price Target170.74 (1269.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-24.53%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)98.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.52%
Valuation
Industry RankSector Rank
PE 1.2
Fwd PE N/A
P/S 0.38
P/FCF N/A
P/OCF 5.42
P/B 1.05
P/tB N/A
EV/EBITDA N/A
EPS(TTM)10.36
EY83.11%
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)2.3
OCFY18.45%
SpS32.65
BVpS11.85
TBVpS-6.36
PEG (NY)0.01
PEG (5Y)0.01
Profitability
Industry RankSector Rank
ROA 9.74%
ROE 71.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 26.07%
GM N/A
FCFM N/A
ROA(3y)-5.89%
ROA(5y)-3.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y85.55%
PM growth 5Y32.24%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 4.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 8.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.6
Quick Ratio 0.6
Altman-Z 0.39
F-Score6
WACC5.23%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)13.91%
Cap/Sales(5y)16.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)360.39%
EPS 3Y301.6%
EPS 5Y116.08%
EPS Q2Q%278.1%
EPS Next Y99.7%
EPS Next 2Y41.51%
EPS Next 3Y26.14%
EPS Next 5YN/A
Revenue 1Y (TTM)11.04%
Revenue growth 3Y9.84%
Revenue growth 5Y8.73%
Sales Q2Q%11.4%
Revenue Next Year6.41%
Revenue Next 2Y9.12%
Revenue Next 3Y8.11%
Revenue Next 5YN/A
EBIT growth 1Y81.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year127.08%
EBIT Next 3Y32.13%
EBIT Next 5YN/A
FCF growth 1Y-135.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.64%
OCF growth 3Y-22.21%
OCF growth 5Y-2.48%